Yanggang Yuan

Dr. Yanggang Yuan


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Experimental Cell Research
Verified
Journal Article
Closed access
CZChuanyan Zhao
Chuanyan Zhao
ZCZhuyun Chen
Zhuyun Chen
XXXueqiang Xu
Xueqiang Xu
XAXiaofei An
Xiaofei An
SDSuyan Duan
Suyan Duan
YYYanggang Yuan
Yanggang Yuan

18 February 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
CZChuanyan Zhao
Chuanyan Zhao
ZCZhuyun Chen
Zhuyun Chen
JQJia Qi
Jia Qi
SDSuyan Duan
Suyan Duan
ZHZhimin Huang
Zhimin Huang
YYYanggang Yuan
Yanggang Yuan
Drp1-dependent mitophagy protects against cisplatin-induced apoptosis of renal tubular epithelial cells by improving mitochondrial function Drp1-dependent mitophagy protects against cisplatin-induced apoptosis of renal tubular epithelial cells by improving mitochondrial function

9 March 2018 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
JQJia Qi
Jia Qi
FWFeng Wang
Feng Wang
PYPing Yang
Ping Yang
XWXuelian Wang
Xuelian Wang
RXRenjie Xu
Renjie Xu
JDJunli Duan
Junli Duan
Hypertension-induced cardiac apoptosis is a major contributor to early-stage heart-failure. Our previous studies have found that p53-mediated mitochondrial fission is involved in aldosterone-induced podocyte apoptosis. However, it is not clear that whether p53-induced mitochondrial fission is critical for hypertensive Angiotensin II (AngII)-induced cardiomyocyte apoptosis. In this study, we found that inhibition of the mitochondrial fission protein Drp1 (dynamin-related protein 1) by Mdivi-1 prevented cardiomyocyte apoptosis and cardiac remodeling in SHRs. In vitro we found that treatment of cultured neonatal rat cardiomyocytes with AngII induced Drp1 expression, mitochondrial fission, and apoptosis. Knockdown of Drp1 inhibited AngII-induced mitochondrial fission and cardiomyocyte apoptosis. Furthermore, AngII induced p53 acetylation. Knockdown of p53 inhibited AngII-induced Drp1 expression, mitochondrial fission, and cardiomyocyte apoptosis. Besides, we found that Sirt1 was able to reverse AngII-induced p53 acetylation and its binding to the Drp1 promoter, which subsequently inhibited mitochondrial fission and eventually attenuated cardiomyocyte apoptosis. Collectively, these results suggest that AngII degrades Sirt1 to increase p53 acetylation, which induces Drp1 expression and eventually results in cardiomyocyte apoptosis. Sirt1/p53/Drp1dependent mitochondrial fission may be a valuable therapeutic target for hypertension induced heart failure.

9 June 2024 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
RYRong Yang
Rong Yang
HZHeng Zhang
Heng Zhang
SCSi Chen
Si Chen
KLKaibin Lou
Kaibin Lou
MZMeng Zhou
Meng Zhou
HLHongwei Liang
Hongwei Liang
Migrasomes represent a recently uncovered category of extracellular microvesicles, spanning a diameter range of 500 to 3000 nm. They are emitted by migrating cells and harbour a diverse array of RNAs and proteins. Migrasomes can be readily identified in bodily fluids like serum and urine, rendering them a valuable non‐invasive source for disease diagnosis through liquid biopsy. In this investigation, we introduce a streamlined and effective approach for the capture and quantitative assessment of migrasomes, employing wheat germ agglutinin (WGA)‐coated magnetic beads and flow cytometry (referred to as WBFC). Subsequently, we examined the levels of migrasomes in the urine of kidney disease (KD) patients with podocyte injury and healthy volunteers using WBFC. The outcomes unveiled a substantial increase in urinary podocyte‐derived migrasome concentrations among individuals with KD with podocyte injury compared to the healthy counterparts. Notably, the urinary podocyte‐derived migrasomes were found to express an abundant quantity of phospholipase A2 receptor (PLA2R) proteins. The presence of PLA2R proteins in these migrasomes holds promise for serving as a natural antigen for the quantification of autoantibodies against PLA2R in the serum of patients afflicted by membranous nephropathy. Consequently, our study not only pioneers a novel technique for the isolation and quantification of migrasomes but also underscores the potential of urinary migrasomes as a promising biomarker for the early diagnosis of KD with podocyte injury.

2 September 2018 in Free Radical Research
Verified
Journal Article
Closed access
XLXi Liu
Xi Liu
WCWei Cao
Wei Cao
JQJia Qi
Jia Qi
QLQing Li
Qing Li
MZMin Zhao
Min Zhao
YXYing chang Xing
Ying chang Xing
Leonurine, a major bioactive component from Herba Leonuri, shows therapeutic potential in several diseases, including diabetes, cardiovascular disease, bovine mastitis and depression. In kidney, it was reported that leonurine was performing a protective effect in both acute kidney injury and renal fibrosis mice models. The aim of this study is to investigate the effect of leonurine in podocyte injury. In the mice model of adriamycin (ADR) -induced nephropathy, the application of leonurine significantly prevented early kidney damage, macrophage infiltration and proteinuria. Meanwhile, leonurine suppressed ADR-induced podocyte injury and reactive oxygen species (ROS) production. Consistent to in vivo results, leonurine prevented ADR-induced podocyte injury and ROS production in cultured human podocytes. All these results suggested that leonurine might suppress ADR-induced podocyte injury via inhibiting oxidative stress. Leonurine might be a novel therapeutic drug for prevention of glomerular diseases.

1 October 2020 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
SDSuyan Duan
Suyan Duan
JCJiajia Chen
Jiajia Chen
LWLin Wu
Lin Wu
GNGuangyan Nie
Guangyan Nie
LSLianqin Sun
Lianqin Sun
YYYanggang Yuan
Yanggang Yuan